文献速递膀胱癌与上尿路尿路上皮癌

局部肌层浸润性膀胱尿路上皮癌三联疗法与根治性膀胱切除术的疗效比较

Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
PubMed 文献 · Eur Urol · 2017-04-12

基于美国国家癌症数据库2004-2011年数据,比较三联疗法(TMT)与根治性膀胱切除术(RC)对肌层浸润性膀胱尿路上皮癌的疗效。IPTW调整后中位总生存TMT组40个月 vs RC组43个月(p=0.3),但含时变协变量的Cox回归显示TMT与长期总生存显著不良相关(HR 1.37,95%CI 1.16-1.59;p<0.001)。作者结论为TMT总体与较差长期OS相关,但RC的生存获益需权衡手术风险,尤其老年患者。

要点

  • IPTW调整后中位总生存TMT组40个月 vs RC组43个月,差异无统计学意义(p=0.3)。
  • 含时变协变量Cox回归中TMT与长期总生存显著不良相关(HR 1.37,95%CI 1.16-1.59;p<0.001)。
  • TMT相对RC的不良治疗效应随年龄增长而减弱(交互作用p=0.004)。

核心结论

  • TMT总体与较差的长期总生存相关,但RC的生存获益需权衡手术风险,尤其老年患者。
  • 作者认为这些结果为初步的,强调需要随机对照试验比较TMT与RC。

研究设计与样本

  • 观察性队列研究,基于美国国家癌症数据库2004-2011年数据。
  • 共纳入1257例(9.8%)接受TMT和11586例(90.2%)接受RC的患者。
  • 采用逆概率治疗加权(IPTW)调整的Kaplan-Meier分析和含时变协变量的Cox回归分析。

主要发现

  • IPTW调整后中位总生存TMT组40个月(95%CI 34-46) vs RC组43个月(95%CI 41-45),p=0.3。
  • 含时变协变量IPTW调整Cox回归中,TMT与长期总生存显著不良相关(HR 1.37,95%CI 1.16-1.59;p<0.001)。
  • 交互作用分析显示TMT相对RC的不良治疗效应随年龄增长而减弱(p=0.004)。
  • 性别(p=0.6)、Charlson合并症指数(p=0.09)或cT分期(p=0.8)无显著交互作用。

临床怎么用

  • 作者结论认为TMT总体与较差长期总生存相关,但RC的生存获益需权衡手术风险,尤其老年患者。
  • 作者认为结果为初步的,强调需要随机对照试验比较TMT与RC。

局限性

  • 原文称这些结果为初步的,并强调需要随机对照试验比较TMT与RC。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Given the lack of randomized evidence comparing trimodal therapy (TMT) to radical cystectomy (RC) for muscle-invasive urothelial carcinoma of the bladder (UCB), we performed an observational cohort study to examine the comparative effectiveness of these two definitive treatments. Within the National Cancer Data Base (2004-2011),we identified 1257 (9.8%) and 11 586 (90.2%) patients who received TMT and RC, respectively. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan-Meier analysis showed that median overall survival (OS) was similar between the TMT (40 mo, 95% confidence interval [CI] 34-46) and RC groups (43 mo 95% CI 41-45; p=0.3). In IPTW-adjusted Cox regression analysis with a time-varying covariate, TMT was associated with a significant adverse impact on long-term OS (hazard ratio 1.37, 95% CI 1.16-1.59; p<0.001). Interaction terms indicated that the adverse treatment effect of TMT versus RC decreased with age (p=0.004), while there was no significant interaction with gender (p=0.6), Charlson comorbidity index (p=0.09) or cT stage (p=0.8). In conclusion, we found that TMT was generally associated with worse long-term OS compared to RC for muscle-invasive UCB. However, the survival benefit of RC should be weighed against the risks of surgery, especially in older patients. These results are preliminary and emphasize the need for a randomized controlled trial to compare TMT versus RC. PATIENT SUMMARY: We examined the comparative effectiveness of trimodal therapy versus radical cystectomy for muscle-invasive urothelial carcinoma of the bladder. We found that trimodal therapy was generally associated with worse long-term overall survival, although there may be no difference with radical cystectomy in older individuals.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Seisen T, Sun M, Lipsitz SR, et al. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. Eur Urol. 2017. PMID: 28412065. doi:10.1016/j.eururo.2017.03.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。